BRIEF published on 05/14/2024 at 22:20, 1 year 11 months ago Sonnet BioTherapeutics Announces Fiscal Year 2024 Q2 Results and Business Updates Financial Results Clinical Trials Oncology Biopharmaceuticals Sonnet BioTherapeutics
BRIEF published on 05/14/2024 at 22:20, 1 year 11 months ago Sonnet BioTherapeutics annonce ses résultats du deuxième trimestre de l'exercice 2024 et des mises à jour sur ses activités Résultats Financiers Essais Cliniques Oncologie Sonnet BioTherapeutics Produits Biopharmaceutiques
BRIEF published on 05/14/2024 at 22:20, 1 year 11 months ago NANOBIOTIX Lance une Étude de Phase 2 sur le Traitement du Cancer du Poumon avec FDA Approval FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3
BRIEF published on 05/14/2024 at 22:20, 1 year 11 months ago NANOBIOTIX Launches Phase 2 Lung Cancer Treatment Study with FDA Approval FDA Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer
BRIEF published on 05/14/2024 at 22:15, 1 year 11 months ago GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025 Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF published on 05/14/2024 at 22:15, 1 year 11 months ago GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025 Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
BRIEF published on 05/14/2024 at 22:10, 1 year 11 months ago Protagonist Therapeutics to Present New Rusfertide Study Data at EHA Congress 2024 Clinical Study Protagonist Therapeutics Rusfertide Polycythemia Vera EHA Congress 2024
BRIEF published on 05/14/2024 at 22:10, 1 year 11 months ago Protagonist Therapeutics présentera de nouvelles données de l'étude Rusfertide au congrès de l'EHA 2024 Étude Clinique Rusfertide Thérapeutique Protagoniste Polyglobulie Vraie Congrès EHA 2024
BRIEF published on 05/14/2024 at 22:10, 1 year 11 months ago Vicinity Motor Corp. Reports Strong First Quarter 2024 Financial Results Financial Results Revenue Growth Electric Vehicles Market Expansion Vicinity Motor Corp
BRIEF published on 05/14/2024 at 22:10, 1 year 11 months ago Vicinity Motor Corp. annonce de solides résultats financiers pour le premier trimestre 2024 Résultats Financiers Vicinity Motor Corp. Véhicules Électriques Hausse Des Revenus L'expansion Du Marché
Published on 04/30/2026 at 08:00, 41 minutes ago Caledonia Mining Corporation Plc: Change of Chairman
Published on 04/30/2026 at 07:15, 1 hour 26 minutes ago Route1 Reports Fiscal Year 2025 Results and Continued Transition Toward Recurring, Lifecycle-Based Revenue
Published on 04/30/2026 at 01:35, 7 hours 6 minutes ago Kalo Gold Provides Update on High-Resolution Airborne Magnetic Survey at Vatu Aurum Project, Fiji
Published on 04/30/2026 at 01:15, 7 hours 26 minutes ago Credissential Announces Shares Consolidation
Published on 04/30/2026 at 08:30, 11 minutes ago VAZIVA SA: STRONG GROWTH IN 2025 ANNUAL RESULTS - 2026 OUTLOOK
Published on 04/30/2026 at 08:26, 15 minutes ago XTPL reports record-high revenues, secures further funding and focuses on sales scaling
Published on 04/30/2026 at 08:24, 17 minutes ago InTiCa Systems SE: Publication of the annual reports for 2025 postponed
Published on 04/30/2026 at 08:05, 36 minutes ago Rockwell Automation Demonstrates the Future of Industrial Operations at Interpack 2026
Published on 04/30/2026 at 08:00, 41 minutes ago LDC : Augmentation de capital réservée aux salariés.
Published on 04/30/2026 at 07:45, 56 minutes ago The Belgian State and ENGIE Group enter into exclusive negotiations for the acquisition by Belgium of ENGIE's nuclear activities
Published on 04/30/2026 at 07:45, 56 minutes ago L’État belge et le groupe ENGIE entament des négociations exclusives pour l’acquisition des activités nucléaires d’ENGIE par la Belgique
Published on 04/30/2026 at 07:30, 1 hour 11 minutes ago Nieuwe Gimv Anchor investering: acquisitie van een belang van 5% in Azelis
Published on 04/30/2026 at 07:30, 1 hour 11 minutes ago New Gimv Anchor investment: acquisition of 5% shareholding in Azelis
